Header Logo

Connection

SETH LERNER to src-Family Kinases

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about src-Family Kinases.
SETH LERNER
Connection Strength
0.084
src-Family Kinases
  1. Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling. Mol Cancer Ther. 2010 May; 9(5):1128-35.
    View in: PubMed
    Score: 0.084
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.